Inhibitory Effect of Acetylcholine on Monoamine Oxidase A and B Activity in Different Parts of Rat Brain

 

 Buy Article Permissions and Reprints

Abstract

Acetylcholine (CAS 60-31-1, ACh), which is similar in its chemical structure to the carbamate aldicarb, was found to inhibit brain monoamine oxidase isoenzymes, namely MAO-A and B. The effect of ACh on both isoenzymes extracted from the whole brain of male albino rats and its different parts (frontal cortex, basal ganglia, cerebellum, pons and medulla oblongata) was studied.

The results indicated that ACh inhibited MAO-A from the cerebellum and MAO-B from the basal ganglia more than MAO iso-enzymes from other brain parts. The inhibition was of the competitive type. It was also found that the enzyme inhibitor dissociation constants (Ki) and the affinity constants (Ki/Km) of MAO-A were higher than those of MAO-B.

• References

• 1 Ganong WF. Review of medical physiology. Neurophysiologic basis of instinctual behaviour and motions. 8th ed. Los Altas (CA, USA): Lange Medical Publications; 1977. p. 176-189
  Google Scholar
• 2 Johnston JP. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol. 1968; 17: 1285-1287
  CrossrefPubMedGoogle Scholar
• 3 Ekstedt B. Substrate specificity of the different forms of MAO in rat liver mitochondria. Biochem Pharmacol. 1975; 25: 1133-1138
  PubMedGoogle Scholar
• 4 Thomas T. Monoamine oxidase B-inhibitors in the treatment of Alzheimer’s disease. Neurobiol Aging. 2000; 21 (2) 343-346
  CrossrefPubMedGoogle Scholar
• 5 Osman M.Y., Osman H.M.Y.. Dual effect of aldicarb on acetyl cholinesterase and monoamine oxidase in different parts of rat brain. FASEB. 2007; LB120: LB25
  PubMedGoogle Scholar
• 6 Roth J, Gillis C. Determination of ß-phenylethylamine oxidase. Inhibition by Imipramine. Biochem Pharmacol. 1974; 23: 2537-2540
  CrossrefPubMedGoogle Scholar
• 7 Mohamed YS, Osman MY, Mahfouz MM. effect of acetylcholine on monoamine oxidase. Biochem Pharmacol. 1976; 22: 1665-1667
  PubMedGoogle Scholar
• 8 Osman MY, Abdel-Tawab SM, Sharaf IA. Effect of physostigmine on cholinesterase activity in different parts of rat brain. Arzneimittel-Forschung (Drug Research). 1995; 45 (1) 6 663-665
  PubMedGoogle Scholar
• 9 Lowry OH, Rosebrough NG, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193: 265-9
  PubMedGoogle Scholar
• 10 Udenfried S, Weissbach H, Brodie BB. Assay of serotonin and relaed metabolic enzymes and drugs. In: Methods of biochemical analysis. Glick G. editor London: Interscience; 1958. p. 96-99
  Google Scholar
• 11 Tabor CW, Tabor H, Rosenthal SM. Purification of amine oxidase from beef plasma. J Biol Chem. 1954; 208: 645-661
  PubMedGoogle Scholar
• 12 Dixon M, Webb EC. Enzymes. 2nd ed. London: Longmans; 1964. p. 162
  Google Scholar
• 13 Cleland WW In: The enzymes. vol. 2. 3rd ed. Boyer P. editor New York: Academic Press; 1972. p. 1-33
  Google Scholar
• 14 Mohamed YS, Osman MY, Gabr Y. Inhibition of cholinesterase by 5-hydroxytryptamine. Arzneimittel-Forschung (Drug Research). 1975; 25: 1714-1715
  PubMedGoogle Scholar
• 15 Osman MY, Mahfouz MM, Elhabet AE, ElSherbini H. Inhibition of erythrocyte and plasma cholinesterase by 5-hydroxytryptamine. Arzneimittel-Forschung (Drug Research). 1982; 9: 1120-1122
  PubMedGoogle Scholar
• 16 Naoi M, Maruyama W, Sasuga S, Deng Y, Dostret P, Ohta S, Takahashi T. Inhibition of type A monoamine oxidase by 2(N)-methyl-6, 7-dihydroxyisoquinolinium ions. Neurochemlnt. 1994; 25 (5) 475-481
  PubMedGoogle Scholar
• 17 Veselovsky HV, Ivanov AS, Medvedev F. Is one aminoacid responsible for substrate specificity of monoamine oxidase A and B?. Vobr Med Khim. 1998; 43: 527-536
  PubMedGoogle Scholar
• 18 Shih JC. Molecular basis of human MAO-A and MAO-B. Neuropsychopharmacology. 1991; 4: 1-3
  PubMedGoogle Scholar